by Ian Khan | Oct 10, 2023 | Futurist Blog
Dr. Eric Topol – Founder and Director, Scripps Research Translational Institute: A prolific writer and speaker, Dr. Topol is a prominent advocate for personalized medicine, emphasizing the role of genomics and digital health tools in individualized care.
Dr. Francis Collins – Director, National Institutes of Health (NIH): Having led the Human Genome Project, Dr. Collins is a stalwart in the realm of genomics and its implications for personalized medical treatments.
Dr. Anne Wojcicki – Co-founder and CEO, 23andMe: Through 23andMe, Wojcicki has championed direct-to-consumer genetic testing, providing insights into genetics and promoting a personalized approach to health.
Dr. Craig Venter – Biotechnologist, Genomic Researcher: Renowned for his role in sequencing the human genome, Dr. Venter continues to explore the genomic frontier, emphasizing its role in tailoring medical interventions.
Dr. Leroy Hood – Chief Science Officer, Providence St. Joseph Health; Co-founder, Institute for Systems Biology: Dr. Hood’s pioneering work in systems biology and the invention of automated DNA sequencing has set the stage for personalized medicine’s advancements.
Dr. Jennifer Doudna – Biochemist, University of California, Berkeley: As a key figure in the development of CRISPR gene-editing technology, Dr. Doudna’s work is poised to revolutionize personalized therapeutic interventions.
Dr. George Church – Professor, Harvard Medical School: Renowned for his work in genetics, synthetic biology, and genome sequencing, Dr. Church is at the forefront of exploring genomic applications in personalized therapies.
Dr. Atul Butte – Director, Institute for Computational Health Sciences, UCSF: Dr. Butte focuses on transforming trillions of data points into diagnostics, therapeutics, and new insights into personalized disease prevention.
Dr. Kathy Giusti – Founder and Chief Mission Officer, Multiple Myeloma Research Foundation: Drawing from her own experience with multiple myeloma, Giusti’s foundation accelerates personalized treatment approaches for patients.
Dr. Patrick Soon-Shiong – Surgeon, Entrepreneur, Philanthropist: Dr. Soon-Shiong’s work in developing novel therapies for diabetes and cancer has made him a standout figure in the push for personalized medicine.
by Ian Khan | Oct 10, 2023 | Futurist Blog
Dr. Anthony Atala: Director of the Wake Forest Institute for Regenerative Medicine, Dr. Atala is renowned for his pioneering work in the lab-engineering of organ tissues, especially the bladder. His lab focuses on translating regenerative medicine technologies to patients.
Dr. Ellen Heber-Katz: A researcher at the Wistar Institute, Heber-Katz has made waves with her discoveries related to the regenerative capabilities of mice, suggesting pathways to enhance human regenerative capacities.
Dr. Deepak Srivastava: President of the Gladstone Institutes, his research has pivoted around cardiovascular regeneration. He’s recognized for his work in converting scar tissue in the heart into functioning cardiac cells after an injury.
Dr. Robert Lanza: Chief Scientific Officer of Astellas Institute for Regenerative Medicine, Lanza’s work has primarily revolved around stem cells and their potential in regenerative therapies, particularly retinal diseases.
Dr. Robin Lovell-Badge: Stationed at the Francis Crick Institute, he has made significant contributions to stem cell research and understanding the intricacies of sex determination in embryos, paving the way for targeted therapeutic strategies.
Dr. Sally Temple: Co-founder of the Neural Stem Cell Institute, her work elucidates the mechanisms of neural stem cells in the brain. This has potential implications for therapies in neurodegenerative diseases and brain injuries.
Dr. Alejandro Sánchez Alvarado: A principal investigator at the Stowers Institute for Medical Research, he has delved deep into understanding the regeneration mechanics in planarians, with hopes of extrapolating such capacities to humans.
Dr. Michael Levin: Leading the Allen Discovery Center at Tufts University, Levin’s research is unique, centering on bioelectrical signaling in cells and its role in regeneration. His work suggests that manipulating these signals can drive remarkable regenerative outcomes.
Dr. Masayo Takahashi: A prominent ophthalmologist and researcher at the RIKEN Institute, she pioneered the world’s first clinical trial that used induced pluripotent stem cells (iPSCs) to treat age-related macular degeneration.
Dr. Deepa Bhartiya: Stationed at the National Institute for Research in Reproductive Health in India, her work focuses on very small embryonic-like stem cells (VSELs) and their potential role in regeneration and treating various diseases.
by Ian Khan | Oct 10, 2023 | Futurist Blog
Dr. Eric Lander: A principal leader of the Human Genome Project, Lander’s work at the Broad Institute has been instrumental in exploring genomic foundations of human health and disease.
Dr. Francis Collins: As the Director of the National Institutes of Health (NIH) and a leader in the Human Genome Project, Collins has played a crucial role in pushing genomics to the forefront of medicine.
Dr. Anne Wojcicki: Co-founder and CEO of 23andMe, Wojcicki has popularized direct-to-consumer genetic testing, offering insights into both ancestry and health.
Dr. George Church: A professor at Harvard and MIT, Church’s work spans genomics, gene editing, and gene sequencing. He’s renowned for his advancements in CRISPR and next-generation sequencing.
Dr. Jennifer Doudna: A Nobel laureate recognized for her pioneering work in developing the CRISPR-Cas9 gene-editing system, Doudna’s research holds immense promise for personalized medicine.
Dr. Craig Venter: Known for sequencing the first human genome, Venter’s endeavors at the J. Craig Venter Institute and Human Longevity, Inc. focus on harnessing genomics for individualized health insights.
Dr. Leroy Hood: A leading voice in systems biology, Hood’s work at the Institute for Systems Biology emphasizes P4 medicine – predictive, preventive, personalized, and participatory.
Dr. Atul Butte: As the director of the Institute for Computational Health Sciences at UCSF, Butte focuses on transforming billions of molecular, clinical, and epidemiological data points into diagnostics, therapeutics, and insights.
Dr. Elaine Mardis: Co-executive director of the Institute for Genomic Medicine at Nationwide Children’s Hospital, Mardis is at the forefront of using genomics for cancer diagnosis and treatment.
Dr. Stephen Quake: A co-president of the Chan Zuckerberg Biohub, Quake’s innovations in genomic technology have accelerated the field of personalized medicine, especially in non-invasive prenatal diagnostics.
by Ian Khan | Oct 10, 2023 | Futurist Blog
Dr. Anthony Atala: Director of the Wake Forest Institute for Regenerative Medicine, Atala’s groundbreaking work includes the development of lab-grown organs and tissues for transplantation.
Dr. Deepak Srivastava: President of the Gladstone Institutes, Srivastava’s research focuses on understanding cardiovascular development and harnessing this knowledge to regenerate damaged hearts.
Dr. Ellen Heber-Katz: A researcher at the Wistar Institute, she’s renowned for her work on tissue regeneration, especially concerning the ability of mice to regenerate damaged heart tissue.
Dr. Juan Carlos Izpisua Belmonte: Working at the Salk Institute, Belmonte’s studies span from stem cell research to understanding human aging, aiming to rejuvenate cells and combat degenerative diseases.
Dr. Robin Smith: As the Chair of the Cura Foundation, Smith has been a significant advocate for advancing regenerative medicine to improve patient outcomes and reduce healthcare costs.
Dr. Robert Lanza: Chief Scientific Officer at Astellas Institute for Regenerative Medicine, Lanza’s work in cell therapy and tissue engineering has garnered worldwide attention, particularly his efforts in cloning and pluripotent stem cells.
Dr. Sally Temple: Co-founder of the Neural Stem Cell Institute, Temple’s research focuses on neural stem cells and their potential in treating degenerative diseases like macular degeneration.
Dr. Masayo Takahashi: A leading figure in RIKEN Center for Developmental Biology in Japan, Takahashi’s work on retinal regeneration using induced pluripotent stem cells (iPSCs) holds promise for vision restoration.
Dr. Michael Levin: Director of the Allen Discovery Center at Tufts University, Levin’s research on biologically inspired robots and regenerative medicine challenges traditional boundaries, especially in regenerating complex body parts.
Dr. Molly Shoichet: A professor at the University of Toronto, Shoichet’s interdisciplinary work in chemical engineering and regenerative medicine focuses on tissue and polymer engineering, with an emphasis on spinal cord injury treatments.
